
CleveX
Founded Year
2003Stage
Unattributed VC | AliveTotal Raised
$3.5MLast Raised
$1.8M | 14 yrs agoRevenue
$0000About CleveX
CleveX Inc. is a medical device company that is developing and marketing skin biopsy closure and repair solutions for the dermatology cosmetic surgery and primary care physicians. CleveX (LLC) started out in 2004 as a joint venture between Cleveland Clinic Foundation (Cleveland OH) and IDx Medical Design (Cincinnati OH) to develop and commercialize surgical dermatology and skin repair innovations generated by leading physicians at the Cleveland Clinic. The company's lead technology platform is the ExiClip. The ExiClip is a single-step disposable surgical device that efficiently excises a skin lesion while simultaneously closing and repairing the surgical site.
Missing: CleveX's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: CleveX's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
CleveX Frequently Asked Questions (FAQ)
When was CleveX founded?
CleveX was founded in 2003.
Where is CleveX's headquarters?
CleveX's headquarters is located at 1275 Kinnear Road, Columbus.
What is CleveX's latest funding round?
CleveX's latest funding round is Unattributed VC.
How much did CleveX raise?
CleveX raised a total of $3.5M.
Who are the investors of CleveX?
Investors of CleveX include Plymouth Growth Partners, Reservoir Venture Partners, Ohio TechAngels and Rev1 Ventures.
Who are CleveX's competitors?
Competitors of CleveX include InterRad Medical, OrthAlign, Cohera Medical, SciBase, Small Bone Innovations, MAKO Surgical, ENTrigue Surgical, Caliber Imaging & Diagnostics, Kfx Medical, nFocus Neuromedical and 12 more.
Compare CleveX to Competitors
Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.
CryoPen is a developer and manufacturer of state-of-the art medical devices and aesthetic treatment systems. CryoPen is committed to delivering the most effective, and profitable solutions available to healthcare providers, physicians of all specialties, and medical spas. The company's product portfolio aims to enable physicians to provide a higher quality of care and offer their patients a more diverse array of treatments while generating a substantial revenue stream for their practice. CryoPen's product set addresses a multitude of treatment applications such as laser hair removal, skin rejuvenation, cryosurgery, cellulite reduction, vascular lesions, pigmented lesions, acne, psoriasis, fine lines & wrinkles, scar and tattoo removal, photo facials, and skin tightening. With a dedication to the research and development of technologically advanced devices and equipment, every CryoPen product is designed to create a better patient experience, consistent clinical outcomes, and economic impact on the bottom line of their practice.
Wadsworth Medical Technologies has developed a needle-less wound closure system known as the DermaLOC. The product uses next-generation adhesives and was originally designed for the MIT $50K Competition. The company was founded in 2005 by Dr. Andrew Fox, Dr. Daniel Risking and Jim Mills (Mr. Mills is no longer with the company).
InterRad Medical is developing a catheter anchoring device called SecurAcath Catheter Retention System. The SecurAcath System is a new and method for holding catheters in place over and extended time. The SecurAcath System aims to utilize a very small anchor that deploys just under the skin to hold a catheter securely in place.
Primaeva Medical is an early stage medical device company developing a skin tightening and rejuvenation dermatological device

OrthAlign provides orthopedic surgeons with user-friendly and cost-effect technology for precise alignment.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.